Condition: Type 2 Diabetes Mellitus (T2DM) · Sponsor: Second Affiliated Hospital of Guangxi Medical University
An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients with Type 2 Diabetes Primary Research Objective • To evaluate the safety of Henagliflozin in Chinese patients with type 2 diabetes mellitus (T2DM) in real world. Exploratory Research Objectives * 1\. Improvement in metabolic parameters: To assess changes in metabolic indicators, including glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), 2-hour postprandial plasma glucose (PPG), blood pressure, and body weight, in T2DM patients treated with Henagliflozin. * 2\. Incidence of specific adverse events: To investigate the occurrence of key adverse events, with a focus on hypovolemia, amputation or amputation risk, fractures, urinary tract infections, genital infections, renal impairment, diabetic ketoacidosis, hepatic dysfunction, and severe hypoglycemia. * 3\. Impact on muscle health: To evaluate changes in muscle health indicators, such as skeletal muscle mass index, lean body mass, and grip strength, in T2DM patients receiving Henagliflozin therapy.
This description comes directly from the study's public registry record.
Yuzhen Liang · +8613517665676 · liangyuzhen26@163.com
Always discuss trial participation with your own doctor first.
| The People's Hospital of Beihai | Beihai, Guangxi, China | Not Yet Recruiting |
| Guilin Municipal Hospital of Traditional Chinese Medicine | Guilin, Guangxi, China | Not Yet Recruiting |
| Nanxishan Hospital of Guangxi Zhuang Autonomous Region | Nanning, Guangxi, China | Not Yet Recruiting |
| The People's Hospital of Guangxi Zhuang Autonomous Region | Nanning, Guangxi, China | Not Yet Recruiting |
| The People's Hospital of Guangxi Zhuang Autonomous Region | Nanning, Guangxi, China | Not Yet Recruiting |
| the Second Affiliated Hospital of Guangxi Medical University | Nanning, Guangxi, China | Recruiting |
| Qingdao Aikangyi Internet Hospital | Qingdao, Shandong, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06959030